Report Overview
Lipid Metabolism Disease refers to a group of disorders that affect the metabolism of lipids (fats), including cholesterol and triglycerides, within the body.
These disorders may lead to conditions such as hyperlipidemia, hypercholesterolemia, and lipid storage diseases, and are often associated with cardiovascular complications, obesity, and diabetes.
The market for lipid metabolism disease treatment encompasses a range of pharmaceutical interventions such as Over-the-Counter (OTC) and prescription (Rx) drugs, aimed at managing or correcting lipid imbalances in patients.
Competitor Analysis
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Boehringer Ingelheim
KOWA
